| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 7, 2022 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Buy | 113,114 | $149.15 | $16,871,518.67 | +1.0% | +32.9% | +77.2% | |
| Sep 7, 2022 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Buy | 113,114 | $149.15 | $16,871,518.67 | +1.0% | +32.9% | +77.2% | |
| Sep 6, 2022 | FLGT Fulgent Genetics, Inc. | Kim Paul77 | CFO And Treasurer | Sell | 662 | $41.39 | $27,402.96 | -0.4% | -15.2% | -25.1% | |
| Sep 2, 2022 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $2.14 | $214,137.70 | - | -31.5% | -15.0% | |
| Sep 2, 2022 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer | Sell | 420 | $3.33 | $1,398.60 | -0.3% | -14.7% | -42.2% | |
| Sep 2, 2022 | PSNL Personalis, Inc. | Tachibana Aaron68 | Chief Financial Officer | Sell | 4,168 | $3.33 | $13,879.44 | -1.8% | -14.7% | -42.2% | |
| Sep 2, 2022 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Buy | 90,790 | $144.77 | $13,143,379.24 | +0.8% | +48.1% | +87.9% | |
| Sep 2, 2022 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Buy | 90,790 | $144.77 | $13,143,379.24 | +0.8% | +48.1% | +87.9% | |
| Sep 1, 2022 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 7,704 | $28.08 | $216,328.32 | -3.2% | -17.0% | -30.8% | |
| Sep 1, 2022 | BIAF Bioaffinity Technologies, Inc. | Edwards James Michael | Chief Financial Officer | Buy | 2,448 | $0.00 | - | +8.8% | -67.5% | -78.3% | |
| Aug 31, 2022 | BIAF Bioaffinity Technologies, Inc. | Knight Peter S | Director | Buy | 8,163 | $0.00 | - | +57.1% | -68.7% | -79.2% | |
| Aug 31, 2022 | BIAF Bioaffinity Technologies, Inc. | Zannes Maria | President, CEO | Buy | 16,326 | $0.00 | - | +457.2% | -68.7% | -79.2% | |
| Aug 31, 2022 | BIAF Bioaffinity Technologies, Inc. | Diamond Stuart | Director | Buy | 4,081 | $0.00 | - | New | -68.7% | -79.2% | |
| Aug 31, 2022 | BIAF Bioaffinity Technologies, Inc. | Rubin Gary D | Director, 10% Owner | Buy | 16,326 | $0.00 | - | +1.0% | -68.7% | -79.2% | |
| Aug 31, 2022 | BIAF Bioaffinity Technologies, Inc. | Anderson Robert A. | Director | Buy | 4,081 | $0.00 | - | New | -68.7% | -79.2% | |
| Aug 31, 2022 | BIAF Bioaffinity Technologies, Inc. | Girgenti Steven | Executive Chairman | Buy | 40,916 | $0.00 | - | +5.0% | -68.7% | -79.2% | |
| Aug 30, 2022 | FLGT Fulgent Genetics, Inc. | Xie Jian77 | President And COO | Sell | 675 | $44.18 | $29,823.53 | -0.2% | -18.7% | -24.0% | |
| Aug 30, 2022 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 10,359 | $29.55 | $306,138.05 | -0.5% | -29.8% | -32.2% | |
| Aug 26, 2022 | MTD Mettler Toledo International Inc/ | Filliol Olivier A71 | Director | Sell | 374 | $1,314.05 | $491,454.94 | -73.6% | +15.8% | -6.1% | |
| Aug 25, 2022 | AWHL Aspira Women's Health Inc. | Fralick Celeste Rachelle | Director | Buy | 6,667 | $0.00 | - | +6.9% | - | - | |
| Aug 25, 2022 | AWHL Aspira Women's Health Inc. | Merchant Minh Hoang | General Counsel &Secretary | Buy | 26,667 | $0.00 | - | +76.9% | - | - | |
| Aug 25, 2022 | AWHL Aspira Women's Health Inc. | Phan Ryan Thinh | CSO &COO | Buy | 46,667 | $0.00 | - | +1,556% | - | - | |
| Aug 25, 2022 | AWHL Aspira Women's Health Inc. | Auerbach Robert D | Director | Buy | 66,667 | $0.00 | - | +121.6% | - | - | |
| Aug 25, 2022 | AWHL Aspira Women's Health Inc. | Sharma Ruby | Director | Buy | 13,332 | $0.00 | - | +11.7% | - | - | |
| Aug 25, 2022 | AWHL Aspira Women's Health Inc. | Schuler Jack W45 | 10% Owner | Buy | 133,333 | $0.00 | - | +0.5% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.